CEM-Plate and CEM-Cage Devices for Cervical Disc Disorder
Trial Summary
What is the purpose of this trial?
This trial tests the safety and effectiveness of the CEM-Cage and CEM-Plate in patients needing a specific neck surgery. These devices help stabilize and fuse neck bones after damaged discs are removed. The study will monitor patients for an extended period to ensure successful healing and device performance.
Do I need to stop my current medications for the trial?
The trial information does not specify if you need to stop taking your current medications. However, if you are on high-dose steroids or investigational drugs, you may not be eligible to participate.
What data supports the effectiveness of the CEM-Plate and CEM-Cage treatment for cervical disc disorder?
Research on similar treatments, like cage-and-plate constructs, shows they are effective for stabilizing the cervical spine and restoring disc height in cervical disc disease. These treatments are commonly used and have been shown to help with conditions requiring cervical decompression and stabilization.12345
Is the CEM-Plate and CEM-Cage treatment safe for humans?
How is the CEM-Plate and CEM-Cage treatment for cervical disc disorder different from other treatments?
The CEM-Plate and CEM-Cage treatment is unique because it combines a plate and cage for cervical spine stabilization, which is designed to restore disc height and provide stability. This approach may differ from other treatments like artificial discs or zero-profile constructs, which focus on maintaining range of motion and minimizing impact on adjacent disc spaces.12459
Research Team
John German, MD
Principal Investigator
Albany Medical College
Eligibility Criteria
This trial is for adults aged 22-79 with neck pain and spinal issues due to cervical disc disorder, who haven't improved after 6 weeks of non-surgical treatment. Candidates must have specific scores on NDI or mJOA scales, confirmed symptoms by imaging, and be able to consent. Exclusions include prior cervical surgeries at the affected levels, certain bone diseases, severe instability or infection in the spine area, high-dose steroid use, substance abuse history, pregnancy, metal allergies and a BMI over 40.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Surgical Procedure
Participants undergo a 2-level anterior cervical discectomy and fusion (ACDF) with the CEM-Cage and CEM-Plate
Post-operative Evaluation
Participants are evaluated at 4 weeks, 3 months, 6 months, 12 months, 18 months, and 24 months post-operatively. Quality of life scales and adverse events are collected. Radiographs are used to assess implant positioning, integrity, and fusion.
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- CEM-Plate and CEM-Cage
Find a Clinic Near You
Who Is Running the Clinical Trial?
ReVivo Medical, Corp.
Lead Sponsor
Albany Medical College
Collaborator
The Cleveland Clinic
Collaborator
IGEA
Industry Sponsor